Michael is a General Partner at Flybridge Capital Partners whose principle investment focus area is the application of "Big Data" platforms across a number of industry verticals. Additionally, Michael is excited about the convergence of healthcare and information technologies, as well as robotics and human-machine interface technologies.

Michael currently represents the firm on the boards of Blue Tarp Financial, MicroCHIPs, PolyRemedy, Predictive Biosciences, SpringLeaf Therapeutics, T2 Biosystems, TARIS Biomedical, and VidSys and led the firm’s investment in lighterliving, Magen BioSciences and Protein Forest. Michael founded IDG Ventures Atlantic in 2001 before it transitioned to Flybridge Capital Partners in 2008. Michael served on the board of International Data Group, the flagship Limited Partner for the IDG Ventures global network of funds. In previous positions, Michael has served on the Boards of a number of public and private companies including FleetCor Technologies (NYSE: FLT), Global TeleSystems Group (NASDAQ: GTSG), El Sitio International (NASDAQ: LCTO), MotherNature.com (NASDAQ: MTHR), Crescent Communications (acquired by Clear Channel), and American Capital Access.

Michael Greeley

General Partner at Flybridge Capital Partners

27

15